Skip to content

A Care Management Intervention for Non-cardiac Chest Pain

A Care Management Intervention for Non-cardiac Chest Pain: Intervention Development and Feasibility Assessment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04904198
Acronym
NCCP
Enrollment
3
Registered
2021-05-27
Start date
2019-03-22
Completion date
2020-01-08
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

non-cardiac chest pain, atypical chest pain, collaborative care

Brief summary

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. Team members including a cardiologist, nurse, and psychiatrist. Impressions and recommendations were shared with the patient's primary care physician. Measures of chest pain severity, frequency and impact and measures of psychological health and health-related quality of life were completed at baseline and intervention completion.

Detailed description

The investigators developed and implemented an eight-week multicomponent care management intervention for non-cardiac chest pain. The care management team consisted of a nurse, cardiologist, and psychiatrist. Following a one-time consultation visit with the cardiologist and nurse, evaluation and treatment recommendations were conveyed to the participant's primary care physician. Then, the nurse completed eight weekly phone calls with the participant to provide support, introduce therapeutic principles, and assist with coordination of care, under the supervision of a psychiatrist. Intervention feasibility was assessed on several domains including adherence, recruitment, attrition, safety, and data collection. To examine preliminary efficacy, participants completed Likert scales of chest pain symptom severity, frequency and impact, and measures of psychological health (Patient Health Questionnaire-9, General Anxiety Disorder-7, Patient Health Questionnaire-15) and health-related quality of life (12-Item Short Form Survey) at baseline and intervention completion.

Interventions

BEHAVIORALCare Management Intervention for non-cardiac chest pain

Multicomponent eight-week care management intervention involving a consultation visit with a cardiologist and nurse. Recommendations from the consultation visit are conveyed to the primary care physician. Following the visit, the participant has eight weekly phone calls with a nurse to provide support, introduce therapeutic principals, and assess symptoms. The study nurse is supervised by a psychiatrist.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of non-cardiac chest pain, defined as chest pain recurring at least once per week for two weeks with at least two of the following objective tests: (1) electrocardiogram without ischemic changes; (2) negative cardiac enzymes; (3) non-ischemic cardiac stress test. * Primary care physician affiliated with the institution

Exclusion criteria

* History or subsequent diagnosis of cardiac disease * Objectively diagnosed alternative medical etiology of chest pain (e.g., gastroesophageal disease) * Resolution of chest pain prior to enrollment * Cognitive impairment, assessed using a six-item screen * Inability to communicate in English * Lack of telephone access (precluding weekly phone call participation).

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of adherenceWeek 8A priori, feasible adherence was defined as 100% completion of the consultation visit and a mean completion of at least half of the eight phone calls over the eight-week study period.

Secondary

MeasureTime frameDescription
Feasibility of intervention attritionWeek 8A priori, an attrition rate of less than or equal to 15% was defined as indicating intervention feasibility
Feasibility of intervention safetyWeek 8Any adverse psychological or physical symptoms were documented throughout the study intervention with appropriate follow-up to ensure safety
Feasibility of data collection at baselineBaselineAssessment of whether participants would be able to complete all baseline study measures
Feasibility of data collection at follow-upWeek 8Assessment of whether participants would be able to complete all follow-up study measures
Change in chest pain symptom severityChange from baseline at week 8Likert scale from 0 (no pain) to 10 (severe pain)
Feasibility of recruitmentBaselineCollect data on the proportion of individuals interested in the study who meet eligibility criteria for participation
Change in chest pain symptom impactChange from baseline at week 8Likert scale from 0 (no impact) to 10 (severe impact)
Change in depressive symptomsChange from baseline at week 8Patient Health Questionnaire-9, score range of 0-27, higher numbers reflect more severe symptoms.
Change in anxiety symptomsChange from baseline at week 8General Anxiety Disorder-7, score range of 0-21, higher numbers reflect more severe symptoms.
Change in somatic symptom disorder/somatization symptomsChange from baseline at week 8Patient Health Questionnaire-15, score range of 0-30, higher numbers reflect more severe symptoms.
Change in health-related quality of lifeChange from baseline at week 812-Item Short Form Survey. Generates a physical health composite summary and a mental health composite summary. The mean score is set to 50 for each composite score. Scores \> 50 indicate better physical or mental health-related quality of life than the mean, and scores \< 50 indicate worse physical or mental health-related quality of life than the mean.
Change in chest pain symptom frequencyChange from baseline at week 8Likert scale from 0 (infrequent) to 10 (very frequent)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026